Sorbitol, Myo-Inositol and Sodium-Potassium ATPase in Diabetic Peripheral Nerve
- 14 Downloads
Slowing of nerve conduction, a hallmark of both experimental and human diabetic neuropathy, is improved or corrected by aldose reductase inhibitors such as sorbinil Animal experiments suggest that a myo-inositol-related defect in nerve sodium-potassium adenosine triphosphatase (ATPase) is responsible for the acute reversible slowing of nerve conduction in diabetes mellitus. This myo-inositol-related defect is at present viewed as a cyclic metabolic defect. Aldose reductase inhibitors have been shown to restore to normal both the myo-inositol content and the sodium-potassium ATPase activity of nerve. This suggests that the acute effects of aldose-reductase inhibitors on nerve conduction in both diabetic animals and human patients may be modified by the correction of an underlying myo-inositol-related defect of nerve sodium-potassium ATPase. Furthermore, this myoinositol-related defect may contribute to other biochemical, functional and structural abnormalities of diabetic peripheral neuropathy.
KeywordsNerve Conduction Diabetic Neuropathy Aldose Reductase Diabetic Peripheral Neuropathy Sorbinil
Unable to display preview. Download preview PDF.
- Day JF, Thorpe SR, Baynes JW. Non-enzymatically glycosylated albumin. In vitro preparation and isolation from normal human serum. Journal of Biological Chemistry 254: 595–597, 1975Google Scholar
- Greene DA, Lattimer SA, Finefold DN, Tamres LK. Impaired Na-dependent amino acid uptake in diabetic peripheral nerve: correction by aldose reductase inhibition or myo-inositol supplementation. Clinical Research 33: 431A, 1985aGoogle Scholar
- Gregersen G, Bertelsen B, Harbo H, Larsen E, Andersen JR, et al. Oral supplementation of myo-inositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurologica Scandinavica 67: 164–172, 1983PubMedCrossRefGoogle Scholar
- Kuwabara T, Kinoshita JH, Cogan DG. Electron microscopic study of galactose-induced cataracts. Investigative Ophthalmology and Visual Science 8: 133–149, 1969Google Scholar
- Nishizuka Y. Protein kinases in signal transduction. TIBS 9: 163–166, 1984Google Scholar
- Pirart J. Diabetes mellitus and its degenerative complications. A prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188, 252–263, 1978Google Scholar
- Ritchie JM. The oxygen consumption of mammalian non-myelinated nerve fibres at rest and during activity. Journal of Physiology (London) 188: 309–329, 1967Google Scholar
- Thomas PK, Eliasson SG. Diabetic neuropathy. In Dyck PJ, et al. (Eds) Peripheral neuropathy, pp. 956–981, Saunders, Philadelphia, 1975Google Scholar
- Thomas PK, Ward JD, Watkins PJ. Diabetic neuropathy. In Keen et al. (Eds) Complications of diabetes, pp. 109–136, Arnold, London, 1982Google Scholar